5亿美元!默沙东收购药明生物爱尔兰疫苗资产

Medaverse
06 Jan

2025年1月6日,药明生物(02269.HK)宣布药明海德爱尔兰(卖方)(公司间接全资附属公司)与MSD International(买方)订立协议,据此,按照协议的条款及条件,卖方已有条件同意出售及买方已有条件同意购买与爱尔兰疫苗设施相关的资产,总对价约为5亿美元(约39亿港元)。爱尔兰疫苗设施是药明生物为默沙东生产商业疫苗产品,以满足默沙东的业务需求而设计及建造的专用设施。对价乃由卖方与买方...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10